Player FM 앱으로 오프라인으로 전환하세요!
Is the world brave enough to agree on a pandemic treaty?
Manage episode 418203022 series 2789582
Four years ago, our lives were upended by the Covid-19 pandemic. Countries locked down, millions became ill, millions died. And when the vaccine finally arrived, it was not fairly distributed. Rich countries bought too many, poor countries waited, with nothing.
“What we saw during the Covid-19 pandemic was collapse. Basically, a complete failure of international cooperation,” says Suerie Moon of Geneva Graduate Institute’s Global Health Centre.
Surely we can do better? Countries are gathering in Geneva to try to hammer out a pandemic treaty. Do they have the vision? And the courage?
“There’s been so much lip service paid to equity, but when it actually comes to nailing down what that means, and how to avoid a repeat, it seems like governments are struggling,” says Kerry Cullinan, deputy editor of Health Policy Watch.
What about the vaccine manufacturers? Are they ready to share?
Thomas Cueni former head of the International Federation of Pharmaceutical Manufacturers told us in 2023: “I’ve always been of the view that no treaty is better than a bad treaty. Have a good treaty, I think it would be great.”
David Reddy, the new director-general of IFPMA, adds that they “remain committed to providing the expertise and know-how of our companies to global efforts to prepare for and respond to future pandemics.”
Are we going to be better equipped for the next pandemic?
“I think it would be an insult to the seven million people plus who died during the pandemic for there not to be a historic agreement,” says Cullinan.
Join host Imogen Foulkes on our Inside Geneva podcast to learn more about this treaty.
This text was updated on May 16, 2024, to mention that Thomas Cueni is now the former head of the International Federation of Pharmaceutical Manufacturers. The interview mentioned in the podcast was recorded in 2023.
Get in touch!
- Email us at insidegeneva@swissinfo.ch
- Twitter: @ImogenFoulkes and @swissinfo_en
Thank you for listening! If you like what we do, please leave a review or subscribe to our newsletter.
For more stories on the international Geneva please visit www.swissinfo.ch/
Host: Imogen Foulkes
Production assitant: Claire-Marie Germain
Distribution: Sara Pasino
Marketing: Xin Zhang
챕터
1. Is the world brave enough to agree on a pandemic treaty? (00:00:00)
2. Global Health Treaty Negotiations Amid COVID-19 (00:00:07)
3. Global Pandemic Treaty Negotiations Complexities (00:08:56)
4. International Health Treaty Negotiations and Impacts (00:26:12)
135 에피소드
Manage episode 418203022 series 2789582
Four years ago, our lives were upended by the Covid-19 pandemic. Countries locked down, millions became ill, millions died. And when the vaccine finally arrived, it was not fairly distributed. Rich countries bought too many, poor countries waited, with nothing.
“What we saw during the Covid-19 pandemic was collapse. Basically, a complete failure of international cooperation,” says Suerie Moon of Geneva Graduate Institute’s Global Health Centre.
Surely we can do better? Countries are gathering in Geneva to try to hammer out a pandemic treaty. Do they have the vision? And the courage?
“There’s been so much lip service paid to equity, but when it actually comes to nailing down what that means, and how to avoid a repeat, it seems like governments are struggling,” says Kerry Cullinan, deputy editor of Health Policy Watch.
What about the vaccine manufacturers? Are they ready to share?
Thomas Cueni former head of the International Federation of Pharmaceutical Manufacturers told us in 2023: “I’ve always been of the view that no treaty is better than a bad treaty. Have a good treaty, I think it would be great.”
David Reddy, the new director-general of IFPMA, adds that they “remain committed to providing the expertise and know-how of our companies to global efforts to prepare for and respond to future pandemics.”
Are we going to be better equipped for the next pandemic?
“I think it would be an insult to the seven million people plus who died during the pandemic for there not to be a historic agreement,” says Cullinan.
Join host Imogen Foulkes on our Inside Geneva podcast to learn more about this treaty.
This text was updated on May 16, 2024, to mention that Thomas Cueni is now the former head of the International Federation of Pharmaceutical Manufacturers. The interview mentioned in the podcast was recorded in 2023.
Get in touch!
- Email us at insidegeneva@swissinfo.ch
- Twitter: @ImogenFoulkes and @swissinfo_en
Thank you for listening! If you like what we do, please leave a review or subscribe to our newsletter.
For more stories on the international Geneva please visit www.swissinfo.ch/
Host: Imogen Foulkes
Production assitant: Claire-Marie Germain
Distribution: Sara Pasino
Marketing: Xin Zhang
챕터
1. Is the world brave enough to agree on a pandemic treaty? (00:00:00)
2. Global Health Treaty Negotiations Amid COVID-19 (00:00:07)
3. Global Pandemic Treaty Negotiations Complexities (00:08:56)
4. International Health Treaty Negotiations and Impacts (00:26:12)
135 에피소드
All episodes
×플레이어 FM에 오신것을 환영합니다!
플레이어 FM은 웹에서 고품질 팟캐스트를 검색하여 지금 바로 즐길 수 있도록 합니다. 최고의 팟캐스트 앱이며 Android, iPhone 및 웹에서도 작동합니다. 장치 간 구독 동기화를 위해 가입하세요.